Skip to main content
. 2020 May 6;19:56. doi: 10.1186/s12933-020-01027-2

Table 2.

Current pharmacological treatment in the T2D patients (n = 28)

Pharmacological treatment
Metformin (%) 89
Only metformin (%) 14
Other oral hypoglicemic drug (%) 43
Metformin + Other oral hypoglicemic drug (%) 38
Insulin (%) 57
Only insulin (%) 4
Insulin + Metformin (%) 50
Insulin + any oral hypoglicemic drug (%) 54
ACE inhibitors (%) 21
Angiotensin receptor blockers (%) 75
Betablockers (%) 36
Thiazides (%) 25
Statins (%) 71
Aspirin (%) 43